Frozen versus fresh corneal graft carriers in Boston keratoprosthesis surgery: 10-year outcomes

Objective: To compare 10-year clinical outcomes of frozen versus fresh corneal graft carriers for the Boston Keratoprosthesis type 1 (KPro). Design: Prospective, non-masked randomized controlled trial. Participants: Nineteen eyes of 19 patients having undergone Boston KPro type 1 implantation using a fresh or frozen graft carrier. Methods: All patients that underwent Boston KPro type 1 implantation by a single experienced surgeon using an allograft carrier between October 2008 and March 2010 at the Centre Hospitalier de l'Universite de Montreal were considered. Patients were excluded if they had a history of prior KPro implantation in the same eye. A subset of the patient cohort enrolled in the initial study protocol of 24 months continued follow-up to 120 months. Participants were randomized to receive either a fresh or frozen corneal graft carrier depending on tissue availability from the eye bank on the day of KPro implantation. Results: Nineteen eyes of 19 patients were included, with 11 in the fresh group and 8 in the frozen group. At 10 years, in the fresh and frozen groups respectively, device retention was 91% and 75%; mean best corrected visual acuity increased from counting fingers preoperatively to 20/300 and 20/125; and incidence of complications per patient was 2.36 and 2.37. There were no statistically significant differences between groups for any of these outcome measures (p > 0.05 for all analyses). Conclusions: Fresh and frozen corneal graft carriers offer similar clinical outcomes for KPro implantation in terms of device retention, change in visual acuity, and rate of complications at 10 years.

Automated summary

This study compares the 10-year clinical outcomes of frozen and fresh corneal graft carriers for Boston Keratoprosthesis type 1 (KPro) implantation. The results show that fresh and frozen corneal graft carriers offer similar clinical outcomes in terms of device retention, change in visual acuity, and rate of complications at 10 years.